263 related articles for article (PubMed ID: 19095974)
1. Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study.
Nambi V; Hoogeveen RC; Chambless L; Hu Y; Bang H; Coresh J; Ni H; Boerwinkle E; Mosley T; Sharrett R; Folsom AR; Ballantyne CM
Stroke; 2009 Feb; 40(2):376-81. PubMed ID: 19095974
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke.
Elkind MS; Tai W; Coates K; Paik MC; Sacco RL
Cerebrovasc Dis; 2009; 27(1):42-50. PubMed ID: 19018137
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2, hormone use, and the risk of ischemic stroke in postmenopausal women.
Wassertheil-Smoller S; Kooperberg C; McGinn AP; Kaplan RC; Hsia J; Hendrix SL; Manson JE; Berger JS; Kuller LH; Allison MA; Baird AE
Hypertension; 2008 Apr; 51(4):1115-22. PubMed ID: 18259035
[TBL] [Abstract][Full Text] [Related]
6. Endothelial function after ST-elevation myocardial infarction in patients with high levels of high-sensitivity CRP and Lp-PLA
Kandhai-Ragunath JJ; de Wagenaar B; Doelman C; van Es J; Jørstad HT; Peters RJG; Doggen CJM; von Birgelen C
Cardiovasc Revasc Med; 2017; 18(3):202-206. PubMed ID: 28110894
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke.
Elkind MS; Tai W; Coates K; Paik MC; Sacco RL
Arch Intern Med; 2006 Oct; 166(19):2073-80. PubMed ID: 17060536
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for acute ischemic stroke in patients with type 2 diabetes mellitus.
Liu J; Li X; Qu J
Medicine (Baltimore); 2023 Nov; 102(47):e36114. PubMed ID: 38013286
[TBL] [Abstract][Full Text] [Related]
9. Association between high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and carotid atherosclerosis: A cross-sectional study.
Liu H; Yao Y; Wang Y; Ji L; Zhu K; Hu H; Chen J; Yang J; Cui Q; Geng B; Liu Q; Li D; Zhou Y
J Cell Mol Med; 2018 Oct; 22(10):5145-5150. PubMed ID: 30094934
[TBL] [Abstract][Full Text] [Related]
10. Severe periodontitis is associated with the serum levels of hypersensitive C reactive protein and lipoprotein-associated phospholipase A2 in the patients of acute ischemic stroke.
Chen C; Zhu J; Deng X; Yang Z; Lin W; Ma Y; Huang S; Chen L; Liu Y; Zhu F
J Clin Neurosci; 2021 Jun; 88():232-236. PubMed ID: 33992190
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-associated phospholipase A₂ is related to plaque stability and is a potential biomarker for acute coronary syndrome.
Chung H; Kwon HM; Kim JY; Yoon YW; Rhee J; Choi EY; Min PK; Hong BK; Rim SJ; Yoon JH; Lee SJ; Park JK; Kim MH; Jo M; Yang JH; Lee BK
Yonsei Med J; 2014 Nov; 55(6):1507-15. PubMed ID: 25323886
[TBL] [Abstract][Full Text] [Related]
12. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.
Blake GJ; Dada N; Fox JC; Manson JE; Ridker PM
J Am Coll Cardiol; 2001 Nov; 38(5):1302-6. PubMed ID: 11691499
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations.
Small AM; Pournamdari A; Melloni GEM; Scirica BM; Bhatt DL; Raz I; Braunwald E; Giugliano RP; Sabatine MS; Peloso GM; Marston NA; Natarajan P
JAMA Cardiol; 2024 Apr; 9(4):385-391. PubMed ID: 38353970
[TBL] [Abstract][Full Text] [Related]
14. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
Corson MA; Jones PH; Davidson MH
Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of lipoprotein-associated phospholipase A
Han L; Zhong C; Bu X; Xu T; Wang A; Peng Y; Xu T; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
Atherosclerosis; 2017 Nov; 266():1-7. PubMed ID: 28934604
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
Anderson JL
Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients.
Delgado P; Chacón P; Penalba A; Pelegri D; García-Berrocoso T; Giralt D; Santamarina E; Ribó M; Maisterra O; Alvarez-Sabín J; Rosell A; Montaner J
Cerebrovasc Dis; 2012; 33(2):150-8. PubMed ID: 22178747
[TBL] [Abstract][Full Text] [Related]
18. Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study.
Tehrani DM; Gardin JM; Yanez D; Hirsch CH; Lloyd-Jones DM; Stein PK; Wong ND
Atherosclerosis; 2013 Dec; 231(2):246-51. PubMed ID: 24267235
[TBL] [Abstract][Full Text] [Related]
19. The role of high-sensitivity C-reactive protein levels in functional outcomes in patients with large-artery atherosclerosis and small-artery occlusion.
Hou D; Liu J; Feng R; Gao Y; Wang Y; Wu J
Neurol Res; 2017 Nov; 39(11):981-987. PubMed ID: 28749740
[TBL] [Abstract][Full Text] [Related]
20. High-sensitivity C-reactive protein as an indicator of ischemic stroke in patients with isolated acute vestibular syndrome: Retrospective observational study.
Lin F; Chen Y; Wan M; Chen W; Jia W
Medicine (Baltimore); 2019 Nov; 98(48):e18097. PubMed ID: 31770230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
